Enovis Corporation ENOV 深 沪
已收盘 06-12 16:00:00 美东时间
21.80
+0.680
+3.22%
华盛通- 最 高21.88
- 今 开20.99
- 成交量 90.77万股
- 最 低 20.65
- 昨 收 21.12
- 总市值 12.55亿
- 52周最高 36.82
- 市盈率 静 --
- 换手率 1.58%
- 52周最低 20.55
- 委 比 19.35%
- 总股本 5756.26万
- 历史最高 176.11
- 量 比 0.84
- 振 幅 5.82%
- 历史最低 -13.31
- 每 手 1
- 风险率 3.71%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BTIG Reiterates Buy on Enovis, Maintains $39 Price Target
BTIG analyst Ryan Zimmerman reiterates Enovis (NYSE:ENOV) with a Buy and maintains $39 price target.
05-22 20:11
美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
Wells Fargo Maintains Overweight on Enovis, Lowers Price Target to $40
Wells Fargo analyst Larry Biegelsen maintains Enovis (NYSE:ENOV) with a Overweight and lowers the price target from $42 to $40.
05-08 21:24
财报速睇 | Enovis Corporation 2026财年Q2营收5.89亿美元，同比增长5.4%；归母净利润亏损0.09亿美元，同比亏损缩窄84.3%
华盛资讯5月7日讯，Enovis Corporation公布2026财年Q2业绩，公司Q2营收5.89亿美元，同比增长5.4%，归母净利润亏损0.09亿美元，同比亏损缩窄84.3%。
05-07 18:51
财报速睇 | Enovis Corporation 2026财年Q2营收5.89亿美元，同比增长5.4%；归母净利润亏损0.09亿美元，同比亏损缩窄84.3%
华盛资讯5月7日讯，Enovis Corporation公布2026财年Q2业绩，公司Q2营收5.89亿美元，同比增长5.4%，归母净利润亏损0.09亿美元，同比亏损缩窄84.3%。
05-07 18:47
Enovis Corporation beats Q1 street estimates
Enovis Corporation press release (ENOV): Q1 Non-GAAP EPS of $0.89 beats by $0.08. Revenue of $589M (+5.4% Y/Y) beats by $16.56M. Enovis reaffirms financial expectations for 2026. Revenue is expected t...
05-07 18:16
Enovis Affirms FY2026 Adj EPS Guidance of $3.52-$3.73 vs $3.62 Est; Affirms FY2026 Sales Guidance of $2.310B-$2.370B vs $2.344B Est
Enovis (NYSE:ENOV) affirms FY2026 Adj EPS guidance from $3.52-$3.73 to $3.52-$3.73 vs $3.62 analyst estimate. Affirms FY2026 sales outlook from $2.310 billion-$2.370 billion to $2.310 billion-$2.370 billion vs $2.344
05-07 18:08
Enovis Q1 Adj. EPS $0.89 Beats $0.82 Estimate, Sales $589.200M Beat $571.131M Estimate
Enovis (NYSE:ENOV) reported quarterly earnings of $0.89 per share which beat the analyst consensus estimate of $0.82 by 8.54 percent. This is a 9.88 percent increase over earnings of $0.81 per share from the same period
05-07 18:07
Compex begins multi-year supplier partnership with Chelsea FC Women
Compex begins multi-year supplier partnership with Chelsea FC Women Compex, part of Enovis, entered multi-year supplier partnership with Chelsea FC Women to provide electrical muscle stimulation devices for player recovery, performance support, pain management. EMS technology to be integrated into c
05-05 22:50
Norwegian Cruise Line, Aura Biosciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session
US stock futures lower, Dow futures down 200 points. Norwegian Cruise Line shares fall after Q1 results, cuts FY guidance. Other stocks also down.
05-04 20:02
